{"id":"https://openalex.org/W2018358459","doi":"https://doi.org/10.1111/j.1349-7006.2012.02253.x","title":"Long\u2010term outcome following imatinib therapy for chronic myelogenous leukemia, with assessment of dosage and blood levels: the JALSG CML202 study","display_name":"Long\u2010term outcome following imatinib therapy for chronic myelogenous leukemia, with assessment of dosage and blood levels: the JALSG CML202 study","publication_year":2012,"publication_date":"2012-02-25","ids":{"openalex":"https://openalex.org/W2018358459","doi":"https://doi.org/10.1111/j.1349-7006.2012.02253.x","mag":"2018358459","pmid":"https://pubmed.ncbi.nlm.nih.gov/22364419","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/7685081"},"language":"en","primary_location":{"id":"doi:10.1111/j.1349-7006.2012.02253.x","doi":"https://doi.org/10.1111/j.1349-7006.2012.02253.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.1349-7006.2012.02253.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1349-7006.2012.02253.x","source":{"id":"https://openalex.org/S175946340","display_name":"Cancer Science","issn_l":"1347-9032","issn":["1347-9032","1349-7006"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Science","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1349-7006.2012.02253.x","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5039801586","display_name":"Kazunori Ohnishi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I13491362","display_name":"Hamamatsu University","ror":"https://ror.org/057vy9683","country_code":"JP","type":"education","lineage":["https://openalex.org/I13491362"]},{"id":"https://openalex.org/I3123035732","display_name":"Hamamatsu University School of Medicine","ror":"https://ror.org/00ndx3g44","country_code":"JP","type":"education","lineage":["https://openalex.org/I3123035732"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"Kazunori Ohnishi","raw_affiliation_strings":["Oncology Center; Hamamatsu University School of Medicine; Hamamatsu"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncology Center; Hamamatsu University School of Medicine; Hamamatsu","institution_ids":["https://openalex.org/I13491362","https://openalex.org/I3123035732"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068249765","display_name":"Chiaki Nakaseko","orcid":"https://orcid.org/0000-0003-1175-226X","observed_orcids":["https://orcid.org/0000-0003-1175-226X"]},"institutions":[{"id":"https://openalex.org/I4210099339","display_name":"Chiba University Hospital","ror":"https://ror.org/0126xah18","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210099339"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Chiaki Nakaseko","raw_affiliation_strings":["Department of Hematology, Chiba University Hospital, Chiba"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, Chiba University Hospital, Chiba","institution_ids":["https://openalex.org/I4210099339"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111936072","display_name":"Jin Takeuchi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I104946051","display_name":"Nihon University","ror":"https://ror.org/05jk51a88","country_code":"JP","type":"education","lineage":["https://openalex.org/I104946051"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Jin Takeuchi","raw_affiliation_strings":["Department of Hematology and Rheumatology; Nihon University School of Medicine; Tokyo"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology and Rheumatology; Nihon University School of Medicine; Tokyo","institution_ids":["https://openalex.org/I104946051"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032187275","display_name":"Shin Fujisawa","orcid":"https://orcid.org/0000-0003-2028-0209","observed_orcids":["https://orcid.org/0000-0003-2028-0209"]},"institutions":[{"id":"https://openalex.org/I2802180866","display_name":"Yokohama City University Medical Center","ror":"https://ror.org/03k95ve17","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I2802180866"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Shin Fujisawa","raw_affiliation_strings":["Department of Hematology Yokohama City University Medical Center Yokohama"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology Yokohama City University Medical Center Yokohama","institution_ids":["https://openalex.org/I2802180866"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060593609","display_name":"Tadashi Nagai","orcid":"https://orcid.org/0000-0003-4559-671X","observed_orcids":["https://orcid.org/0000-0003-4559-671X"]},"institutions":[{"id":"https://openalex.org/I4210153031","display_name":"Jichi Medical University Hospital","ror":"https://ror.org/04at0zw32","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210153031"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Tadashi Nagai","raw_affiliation_strings":["Division of Hematology, Jichi Medical University Hospital, Shimotsuke"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology, Jichi Medical University Hospital, Shimotsuke","institution_ids":["https://openalex.org/I4210153031"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054578501","display_name":"Hirohito Yamazaki","orcid":"https://orcid.org/0000-0003-3018-2098","observed_orcids":["https://orcid.org/0000-0003-3018-2098"]},"institutions":[{"id":"https://openalex.org/I10091056","display_name":"Kanazawa University","ror":"https://ror.org/02hwp6a56","country_code":"JP","type":"education","lineage":["https://openalex.org/I10091056"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Hirohito Yamazaki","raw_affiliation_strings":["Cellular Transplantation Biology; Kanazawa University Graduate School of Medical Science; Kanazawa"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cellular Transplantation Biology; Kanazawa University Graduate School of Medical Science; Kanazawa","institution_ids":["https://openalex.org/I10091056"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083522292","display_name":"Tetsuzo Tauchi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I158929114","display_name":"Tokyo Medical University","ror":"https://ror.org/00k5j5c86","country_code":"JP","type":"education","lineage":["https://openalex.org/I158929114"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Tetsuzo Tauchi","raw_affiliation_strings":["Department of Hematology Tokyo Medical University Tokyo"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology Tokyo Medical University Tokyo","institution_ids":["https://openalex.org/I158929114"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055166332","display_name":"Kiyotoshi Imai","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210113341","display_name":"Sapporo Hokuyu Hospital","ror":"https://ror.org/024czvm93","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210113341"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Kiyotoshi Imai","raw_affiliation_strings":["Department of Hematology Institute for Artificial Organs, Transplantation & Gene Therapy Sapporo Hokuyu Hospital Sapporo"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology Institute for Artificial Organs, Transplantation & Gene Therapy Sapporo Hokuyu Hospital Sapporo","institution_ids":["https://openalex.org/I4210113341"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021667401","display_name":"Naoki Mori","orcid":"https://orcid.org/0000-0002-4176-6120","observed_orcids":["https://orcid.org/0000-0002-4176-6120"]},"institutions":[{"id":"https://openalex.org/I4210136522","display_name":"Tokyo Women's Medical University","ror":"https://ror.org/03kjjhe36","country_code":"JP","type":"education","lineage":["https://openalex.org/I4210136522"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Naoki Mori","raw_affiliation_strings":["Department of Hematology, Tokyo Women's Medical University School of Medicine, Tokyo"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, Tokyo Women's Medical University School of Medicine, Tokyo","institution_ids":["https://openalex.org/I4210136522"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017994748","display_name":"Fumiharu Yagasaki","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210132452","display_name":"Saitama International Medical Center","ror":"https://ror.org/03ftky336","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210132452"]},{"id":"https://openalex.org/I8588240","display_name":"Saitama Medical University","ror":"https://ror.org/04zb31v77","country_code":"JP","type":"education","lineage":["https://openalex.org/I8588240"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Fumiharu Yagasaki","raw_affiliation_strings":["Department of Hematology, International Medical Center, Saitama Medical University, Hidaka"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, International Medical Center, Saitama Medical University, Hidaka","institution_ids":["https://openalex.org/I4210132452","https://openalex.org/I8588240"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069047580","display_name":"Yasuhiro Maeda","orcid":"https://orcid.org/0000-0001-8327-5875","observed_orcids":["https://orcid.org/0000-0001-8327-5875"]},"institutions":[{"id":"https://openalex.org/I916559398","display_name":"Kindai University","ror":"https://ror.org/05kt9ap64","country_code":"JP","type":"education","lineage":["https://openalex.org/I916559398"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yasuhiro Maeda","raw_affiliation_strings":["Department of Hematology Kinki University Faculty of Medicine Osakasayama"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology Kinki University Faculty of Medicine Osakasayama","institution_ids":["https://openalex.org/I916559398"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111484615","display_name":"Noriko Usui","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I115498069","display_name":"Jikei University School of Medicine","ror":"https://ror.org/039ygjf22","country_code":"JP","type":"education","lineage":["https://openalex.org/I115498069"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Noriko Usui","raw_affiliation_strings":["Division of Oncology and Hematology, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Oncology and Hematology, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo","institution_ids":["https://openalex.org/I115498069"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070702322","display_name":"Yasushi Miyazaki","orcid":"https://orcid.org/0000-0003-3683-7147","observed_orcids":["https://orcid.org/0000-0003-3683-7147"]},"institutions":[{"id":"https://openalex.org/I4405285995","display_name":"Atomic Bomb Disease Institute, Nagasaki University","ror":"https://ror.org/00wc6zv93","country_code":"JP","type":"facility","lineage":["https://openalex.org/I43777268","https://openalex.org/I4405285995"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yasushi Miyazaki","raw_affiliation_strings":["Atomic Bomb Disease Institute Nagasaki University Graduate School of Biomedical Sciences Nagasaki"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Atomic Bomb Disease Institute Nagasaki University Graduate School of Biomedical Sciences Nagasaki","institution_ids":["https://openalex.org/I4405285995"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017936080","display_name":"Koichi Miyamura","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210132181","display_name":"Japanese Red Cross Nagoya Daiichi Hospital","ror":"https://ror.org/03f918r09","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I2799517759","https://openalex.org/I4210132181"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Koichi Miyamura","raw_affiliation_strings":["Hematology Division, Japanese Red Cross Nagoya Daiichi Hospital, Nagoya"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hematology Division, Japanese Red Cross Nagoya Daiichi Hospital, Nagoya","institution_ids":["https://openalex.org/I4210132181"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002642944","display_name":"Hitoshi Kiyoi","orcid":"https://orcid.org/0000-0001-6382-9498","observed_orcids":["https://orcid.org/0000-0001-6382-9498"]},"institutions":[{"id":"https://openalex.org/I60134161","display_name":"Nagoya University","ror":"https://ror.org/04chrp450","country_code":"JP","type":"education","lineage":["https://openalex.org/I60134161"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Hitoshi Kiyoi","raw_affiliation_strings":["Department of Hematology and Oncology Nagoya University Graduate School of Medicine Nagoya"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology and Oncology Nagoya University Graduate School of Medicine Nagoya","institution_ids":["https://openalex.org/I60134161"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013146671","display_name":"Shigeki Ohtake","orcid":"https://orcid.org/0000-0003-0112-6564","observed_orcids":["https://orcid.org/0000-0003-0112-6564"]},"institutions":[{"id":"https://openalex.org/I10091056","display_name":"Kanazawa University","ror":"https://ror.org/02hwp6a56","country_code":"JP","type":"education","lineage":["https://openalex.org/I10091056"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Shigeki Ohtake","raw_affiliation_strings":["Department of Clinical Laboratory Science, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Laboratory Science, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan","institution_ids":["https://openalex.org/I10091056"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113454854","display_name":"Tomoki Naoe","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I60134161","display_name":"Nagoya University","ror":"https://ror.org/04chrp450","country_code":"JP","type":"education","lineage":["https://openalex.org/I60134161"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Tomoki Naoe","raw_affiliation_strings":["Department of Hematology and Oncology Nagoya University Graduate School of Medicine Nagoya"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology and Oncology Nagoya University Graduate School of Medicine Nagoya","institution_ids":["https://openalex.org/I60134161"]}]},{"author_position":"last","author":{"id":null,"display_name":"for the Japan Adult Leukemia Study Group","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"for the Japan Adult Leukemia Study Group","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":17,"corresponding_author_ids":["https://openalex.org/A5039801586"],"corresponding_institution_ids":["https://openalex.org/I13491362","https://openalex.org/I3123035732"],"apc_list":{"value":2600,"currency":"USD","value_usd":2600},"apc_paid":null,"fwci":3.2711,"has_fulltext":true,"cited_by_count":44,"citation_normalized_percentile":{"value":0.92332258,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"103","issue":"6","first_page":"1071","last_page":"1078"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11215","display_name":"Chronic Myeloid Leukemia Treatments","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11215","display_name":"Chronic Myeloid Leukemia Treatments","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12104","display_name":"Protein Tyrosine Phosphatases","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/imatinib","display_name":"imatinib","score":0.9710000157356262},{"id":"https://openalex.org/keywords/chronic-myeloid-leukemia","display_name":"chronic myeloid leukemia","score":0.9919999837875366},{"id":"https://openalex.org/keywords/chronic-phase-cml","display_name":"chronic phase CML","score":0.8849999904632568},{"id":"https://openalex.org/keywords/dose-reduction","display_name":"dose reduction","score":0.5519999861717224},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.5260000228881836},{"id":"https://openalex.org/keywords/complete-cytogenetic-response","display_name":"complete cytogenetic response","score":0.8569999933242798},{"id":"https://openalex.org/keywords/major-molecular-response","display_name":"major molecular response","score":0.9490000009536743},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.8569999933242798},{"id":"https://openalex.org/keywords/event-free-survival","display_name":"event-free survival","score":0.9959999918937683},{"id":"https://openalex.org/keywords/japanese-patients","display_name":"Japanese patients","score":0.7139999866485596},{"id":"https://openalex.org/keywords/blood-level-monitoring","display_name":"blood level monitoring","score":0.625}],"concepts":[{"id":"https://openalex.org/C2777583451","wikidata":"https://www.wikidata.org/wiki/Q177094","display_name":"Imatinib","level":3,"score":0.8901785612106323},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8592109680175781},{"id":"https://openalex.org/C2776960273","wikidata":"https://www.wikidata.org/wiki/Q729735","display_name":"Chronic myelogenous leukemia","level":3,"score":0.6854923963546753},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.653152585029602},{"id":"https://openalex.org/C3019892230","wikidata":"https://www.wikidata.org/wiki/Q177094","display_name":"Imatinib mesylate","level":4,"score":0.6502478122711182},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.5933782458305359},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5652708411216736},{"id":"https://openalex.org/C31785415","wikidata":"https://www.wikidata.org/wiki/Q7846541","display_name":"Trough level","level":4,"score":0.4838465750217438},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.3875078856945038},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.3414587378501892},{"id":"https://openalex.org/C2911091166","wikidata":"https://www.wikidata.org/wiki/Q106419912","display_name":"Transplantation","level":2,"score":0.11920428276062012},{"id":"https://openalex.org/C2909675724","wikidata":"https://www.wikidata.org/wiki/Q411648","display_name":"Tacrolimus","level":3,"score":0.05781668424606323},{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000068877","descriptor_name":"Imatinib Mesylate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D001549","descriptor_name":"Benzamides","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010879","descriptor_name":"Piperazines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D010879","descriptor_name":"Piperazines","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D010879","descriptor_name":"Piperazines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D011505","descriptor_name":"Protein-Tyrosine Kinases","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D011505","descriptor_name":"Protein-Tyrosine Kinases","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D011505","descriptor_name":"Protein-Tyrosine Kinases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D015464","descriptor_name":"Leukemia, Myelogenous, Chronic, BCR-ABL Positive","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D015464","descriptor_name":"Leukemia, Myelogenous, Chronic, BCR-ABL Positive","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D016044","descriptor_name":"Fusion Proteins, bcr-abl","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D016044","descriptor_name":"Fusion Proteins, bcr-abl","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D016044","descriptor_name":"Fusion Proteins, bcr-abl","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018450","descriptor_name":"Disease Progression","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018572","descriptor_name":"Disease-Free Survival","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1111/j.1349-7006.2012.02253.x","doi":"https://doi.org/10.1111/j.1349-7006.2012.02253.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.1349-7006.2012.02253.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1349-7006.2012.02253.x","source":{"id":"https://openalex.org/S175946340","display_name":"Cancer Science","issn_l":"1347-9032","issn":["1347-9032","1349-7006"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Science","raw_type":"journal-article"},{"id":"pmid:22364419","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/22364419","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer science","raw_type":"Clinical Trial, Phase II"},{"id":"pmh:oai:pubmedcentral.nih.gov:7685081","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC7685081/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Sci","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1111/j.1349-7006.2012.02253.x","doi":"https://doi.org/10.1111/j.1349-7006.2012.02253.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.1349-7006.2012.02253.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1349-7006.2012.02253.x","source":{"id":"https://openalex.org/S175946340","display_name":"Cancer Science","issn_l":"1347-9032","issn":["1347-9032","1349-7006"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Science","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[{"id":"https://openalex.org/G267004574","display_name":"Analysis of ligand dependent resistance mechanism of RTK inhibitors","funder_award_id":"24591387","funder_id":"https://openalex.org/F4320334764","funder_display_name":"Japan Society for the Promotion of Science"},{"id":"https://openalex.org/G4345183641","display_name":"A functional quantitative receptor assay using flluoscein labeled hormones with a carbohydrate chain for the evaluation of the hormonal replacement therapy","funder_award_id":"21590621","funder_id":"https://openalex.org/F4320334764","funder_display_name":"Japan Society for the Promotion of Science"},{"id":"https://openalex.org/G6378566924","display_name":"Increase of the target inhibition effects on FLT3 based on the glycosylation and cellular localization status","funder_award_id":"21591198","funder_id":"https://openalex.org/F4320334764","funder_display_name":"Japan Society for the Promotion of Science"}],"funders":[{"id":"https://openalex.org/F4320321945","display_name":"Ministry of Health, Labour and Welfare","ror":"https://ror.org/03mwa7s65"},{"id":"https://openalex.org/F4320334764","display_name":"Japan Society for the Promotion of Science","ror":"https://ror.org/00hhkn466"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2018358459.pdf","grobid_xml":"https://content.openalex.org/works/W2018358459.grobid-xml"},"referenced_works_count":29,"referenced_works":["https://openalex.org/W173353213","https://openalex.org/W1153362793","https://openalex.org/W1799579309","https://openalex.org/W1978821257","https://openalex.org/W1986635169","https://openalex.org/W1991417422","https://openalex.org/W2000354804","https://openalex.org/W2014933948","https://openalex.org/W2026908855","https://openalex.org/W2028959752","https://openalex.org/W2036862498","https://openalex.org/W2048809946","https://openalex.org/W2055515709","https://openalex.org/W2061681412","https://openalex.org/W2065301303","https://openalex.org/W2079517811","https://openalex.org/W2084452268","https://openalex.org/W2102799478","https://openalex.org/W2107268345","https://openalex.org/W2151486690","https://openalex.org/W2153484612","https://openalex.org/W2157436488","https://openalex.org/W2158884958","https://openalex.org/W2166270808","https://openalex.org/W2166654361","https://openalex.org/W2172189430","https://openalex.org/W2243427198","https://openalex.org/W2261840157","https://openalex.org/W2566146173"],"related_works":["https://openalex.org/W2555878248","https://openalex.org/W2549207213","https://openalex.org/W2065301303","https://openalex.org/W2593741544","https://openalex.org/W2000354804","https://openalex.org/W2061681412","https://openalex.org/W2577095545","https://openalex.org/W2581704088","https://openalex.org/W2169257555","https://openalex.org/W1968232397"],"abstract_inverted_index":{"A":[0],"prospective":[1],"multicenter":[2],"Phase":[3],"II":[4],"study":[5],"was":[6,72,84],"performed":[7,85],"to":[8,28,79,87,186,224,234],"examine":[9],"the":[10,88,93,131,149,167,180,187,236],"efficacy":[11,178],"and":[12,53,66,113,128,133,142,177],"safety":[13],"of":[14,61,97,139,199,218,239],"imatinib":[15,30,35,70,159,202,210],"therapy":[16],"in":[17,74,126,157,169,179],"newly":[18],"diagnosed":[19],"Japanese":[20,219],"patients":[21,76,168,220],"with":[22,205],"chronic-phase":[23],"CML.":[24],"Patients":[25],"were":[26,37,64,122,153,183],"scheduled":[27],"receive":[29],"400":[31,200,225],"mg":[32,100,107,115,201,209,226],"daily.":[33],"Plasma":[34],"concentrations":[36],"measured":[38],"by":[39],"liquid":[40],"chromatography-tandem":[41],"mass":[42],"spectrometry.":[43],"In":[44],"481":[45],"evaluable":[46],"patients,":[47],"estimated":[48],"7-year":[49],"overall":[50],"survival":[51,55],"(OS)":[52],"event-free":[54],"(EFS)":[56],"at":[57],"a":[58,196,215],"median":[59],"follow-up":[60],"65":[62],"months":[63,96],"93%":[65],"87%,":[67],"respectively.":[68],"Because":[69],"dosage":[71],"reduced":[73],"many":[75],"due":[77],"mainly":[78],"adverse":[80],"events,":[81],"subgroup":[82],"analysis":[83],"according":[86],"mean":[89,158],"daily":[90,197],"dose":[91,198,238],"during":[92],"first":[94],"24":[95],"treatment:":[98],"\u2265360":[99],"(400-mg":[101],"group;":[102,109,117],"n":[103,110,118],"=":[104,111,119],"294),":[105],"270-359":[106],"(300-mg":[108],"90)":[112],"<270":[114],"(200-mg":[116],"67).":[120],"There":[121,152],"no":[123,154],"significant":[124,155],"differences":[125,156],"OS":[127],"EFS":[129],"between":[130,148,162],"300-":[132],"400-mg":[134],"groups;":[135],"however,":[136],"cumulative":[137],"rates":[138],"complete":[140],"cytogenetic":[141],"major":[143],"molecular":[144],"responses":[145],"differed":[146],"significantly":[147],"two":[150,164,189],"groups.":[151,190],"trough":[160,171],"levels":[161,172],"these":[163],"groups":[165],"for":[166,214],"whom":[170],"had":[173],"been":[174],"measured.":[175],"Survival":[176],"200-mg":[181],"group":[182],"markedly":[184],"inferior":[185],"former":[188],"These":[191],"results":[192],"suggest":[193],"that,":[194],"although":[195],"is":[203],"associated":[204],"better":[206],"outcomes,":[207],"300":[208],"may":[211],"be":[212,232],"adequate":[213],"considerable":[216],"number":[217],"who":[221],"are":[222],"intolerant":[223],"imatinib.":[227,240],"Blood":[228],"level":[229],"monitoring":[230],"would":[231],"useful":[233],"determine":[235],"optimal":[237]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":6},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":3},{"year":2019,"cited_by_count":4},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":5},{"year":2014,"cited_by_count":4},{"year":2013,"cited_by_count":5},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2016-06-24T00:00:00"}